70
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Enhancement of antitumor activity by using a fully human gene encoding a single-chain fragmented antibody specific for carcinoembryonic antigen

, , , &
Pages 3979-3990 | Published online: 22 Aug 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Cong Chen, Yan-Mei Gu, Fan Zhang, Zheng-Chao Zhang, Ya-Ting Zhang, Yi-Di He, Ling Wang, Ning Zhou, Fu-Tian Tang, Hong-Jian Liu & Yu-Min Li. (2021) Construction of PD1/CD28 chimeric-switch receptor enhances anti-tumor ability of c-Met CAR-T in gastric cancer. OncoImmunology 10:1.
Read now

Articles from other publishers (6)

Qiang Feng, Baozhen Sun, Tianyi Xue, Rong Li, Chao Lin, Yongjian Gao, Liqun Sun, Yue Zhuo & Dongxu Wang. (2022) Advances in CAR T-cell therapy in bile duct, pancreatic, and gastric cancers. Frontiers in Immunology 13.
Crossref
Elnaz Faghfuri, Mahdi Abdoli Shadbad, Amir Hossein Faghfouri & Narges Soozangar. (2022) Cellular immunotherapy in gastric cancer: adoptive cell therapy and dendritic cell-based vaccination. Immunotherapy 14:6, pages 475-488.
Crossref
Raghav Chandra, Neeraja Balachandar, Sam Wang, Scott Reznik, Herbert Zeh & Matthew Porembka. (2020) The changing face of gastric cancer: epidemiologic trends and advances in novel therapies. Cancer Gene Therapy 28:5, pages 390-399.
Crossref
Riccardo Dolcetti & Valli De Re. 2019. Gastric Cancer In The Precision Medicine Era. Gastric Cancer In The Precision Medicine Era 189 212 .
Riccardo Dolcetti, Valli De Re & Vincenzo Canzonieri. (2018) Immunotherapy for Gastric Cancer: Time for a Personalized Approach?. International Journal of Molecular Sciences 19:6, pages 1602.
Crossref
Cong Chen, Yan-mei Gu, Zheng-chao Zhang, Ya-ting Zhang, Yi-di He, Fu-tian Tang, Hong-jian Liu & Yu-min Li. (2020) Construction of PD1/CD28 Fusion Receptor Enhances Anti-Tumor Ability of c-Met CAR-T in Gastric Cancer. SSRN Electronic Journal.
Crossref